FDA Approves Unknown Drug — UNICHEM
UNICHEM announced FDA approval of ANDA 219593 effective April 30, 2026, a milestone expected to bolster its market presence and diversify its revenue streams within the generic pharmaceutical sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day